177 related articles for article (PubMed ID: 19582894)
1. Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats.
Lebrecht D; Venhoff AC; Kirschner J; Wiech T; Venhoff N; Walker UA
J Acquir Immune Defic Syndr; 2009 Jul; 51(3):258-63. PubMed ID: 19582894
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction and electron transport chain complex defect in a rat model of tenofovir disoproxil fumarate nephrotoxicity.
Ramamoorthy H; Abraham P; Isaac B
J Biochem Mol Toxicol; 2014 Jun; 28(6):246-55. PubMed ID: 24615786
[TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cells.
Vidal F; Domingo JC; Guallar J; Saumoy M; Cordobilla B; Sánchez de la Rosa R; Giralt M; Alvarez ML; López-Dupla M; Torres F; Villarroya F; Cihlar T; Domingo P
Antimicrob Agents Chemother; 2006 Nov; 50(11):3824-32. PubMed ID: 16940060
[TBL] [Abstract][Full Text] [Related]
4. Tenofovir renal toxicity targets mitochondria of renal proximal tubules.
Kohler JJ; Hosseini SH; Hoying-Brandt A; Green E; Johnson DM; Russ R; Tran D; Raper CM; Santoianni R; Lewis W
Lab Invest; 2009 May; 89(5):513-9. PubMed ID: 19274046
[TBL] [Abstract][Full Text] [Related]
5. Tenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transporters.
Kohler JJ; Hosseini SH; Green E; Abuin A; Ludaway T; Russ R; Santoianni R; Lewis W
Lab Invest; 2011 Jun; 91(6):852-8. PubMed ID: 21403643
[TBL] [Abstract][Full Text] [Related]
6. Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion.
Tanji N; Tanji K; Kambham N; Markowitz GS; Bell A; D'agati VD
Hum Pathol; 2001 Jul; 32(7):734-40. PubMed ID: 11486172
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of mitochondrial DNA content and enzyme levels in tenofovir DF-treated rats, rhesus monkeys and woodchucks.
Biesecker G; Karimi S; Desjardins J; Meyer D; Abbott B; Bendele R; Richardson F
Antiviral Res; 2003 May; 58(3):217-25. PubMed ID: 12767469
[TBL] [Abstract][Full Text] [Related]
8. Depletion of the cellular antioxidant system contributes to tenofovir disoproxil fumarate - induced mitochondrial damage and increased oxido-nitrosative stress in the kidney.
Abraham P; Ramamoorthy H; Isaac B
J Biomed Sci; 2013 Aug; 20(1):61. PubMed ID: 23957306
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal study on mitochondrial effects of didanosine-tenofovir combination.
López S; Negredo E; Garrabou G; Puig J; Ruiz L; Sanjurjo E; Ramos X; Infante AB; Casademont J; Cardellach F; Clotet B; Miró O
AIDS Res Hum Retroviruses; 2006 Jan; 22(1):33-9. PubMed ID: 16438643
[TBL] [Abstract][Full Text] [Related]
10. Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors.
Birkus G; Hitchcock MJ; Cihlar T
Antimicrob Agents Chemother; 2002 Mar; 46(3):716-23. PubMed ID: 11850253
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors.
Venhoff N; Setzer B; Melkaoui K; Walker UA
Antivir Ther; 2007; 12(7):1075-85. PubMed ID: 18018766
[TBL] [Abstract][Full Text] [Related]
12. Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors.
Cihlar T; Birkus G; Greenwalt DE; Hitchcock MJ
Antiviral Res; 2002 Apr; 54(1):37-45. PubMed ID: 11888656
[TBL] [Abstract][Full Text] [Related]
13. BMS-986001, an HIV nucleoside reverse transcriptase inhibitor, does not degrade mitochondrial DNA in long-term primary cultures of cells isolated from human kidney, muscle, and adipose tissue.
Wang F; Flint OP
Antimicrob Agents Chemother; 2013 Dec; 57(12):6205-12. PubMed ID: 24080659
[TBL] [Abstract][Full Text] [Related]
14. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy.
Côté HC; Magil AB; Harris M; Scarth BJ; Gadawski I; Wang N; Yu E; Yip B; Zalunardo N; Werb R; Hogg R; Harrigan PR; Montaner JS
Antivir Ther; 2006; 11(1):79-86. PubMed ID: 16518963
[TBL] [Abstract][Full Text] [Related]
15. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.
Herlitz LC; Mohan S; Stokes MB; Radhakrishnan J; D'Agati VD; Markowitz GS
Kidney Int; 2010 Dec; 78(11):1171-7. PubMed ID: 20811330
[TBL] [Abstract][Full Text] [Related]
16. Tenofovir disoproxil fumarate: toxicity, toxicokinetics, and toxicogenomics analysis after 13 weeks of oral administration in mice.
Ng HH; Stock H; Rausch L; Bunin D; Wang A; Brill S; Gow J; Mirsalis JC
Int J Toxicol; 2015; 34(1):4-10. PubMed ID: 25568137
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin.
Lebrecht D; Kokkori A; Ketelsen UP; Setzer B; Walker UA
J Pathol; 2005 Dec; 207(4):436-44. PubMed ID: 16278810
[TBL] [Abstract][Full Text] [Related]
18. Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy.
Perazella MA
Kidney Int; 2010 Dec; 78(11):1060-3. PubMed ID: 21076445
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of megalin and cubilin and altered mitochondrial activity in tenofovir nephrotoxicity.
Cez A; Brocheriou I; Lescure FX; Adam C; Girard PM; Pialoux G; Moestrup SK; Fellahi S; Bastard JP; Ronco P; Plaisier E
Hum Pathol; 2018 Mar; 73():89-101. PubMed ID: 29309806
[TBL] [Abstract][Full Text] [Related]
20. Effects of of didanosine-related depletion of mtDNA in human T lymphocytes.
Setzer B; Schlesier M; Walker UA
J Infect Dis; 2005 Mar; 191(6):848-55. PubMed ID: 15717258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]